Showing 1 - 10 results of 10 for search 'Falk G Bechara', query time: 0.03s
Refine Results
-
1
-
2
Waiving Subsequent Complete Lymph Node Dissection in Melanoma Patients with Positive Sentinel Lymph Node Does Not Result in Worse Outcome on 20-Year Analysis by Laura Susok, Celine Nick, Jürgen C. Becker, Falk G. Bechara, Markus Stücker, Waldemar Uhl, Thilo Gambichler
Published 2021-10-01
Article -
3
-
4
-
5
Primary Thyroid Dysfunction Is Prevalent in Hidradenitis Suppurativa and Marked by a Signature of Hypothyroid Graves’ Disease: A Case–Control Study by Nessr Abu Rached, Johannes W. Dietrich, Lennart Ocker, Daniel R. Quast, Christina Scheel, Thilo Gambichler, Falk G. Bechara
Published 2023-12-01
Article -
6
Dicer Sequencing, Whole Genome Methylation Profiling, mRNA and smallRNA Sequencing Analysis in Basal Cell Carcinoma by Michael Sand, Annabelle Bromba, Daniel Sand, Thilo Gambichler, Schapoor Hessam, Jürgen C. Becker, Eggert Stockfleth, Thomas Meyer, Falk G. Bechara
Published 2019-10-01
Article -
7
Screening for Diabetes Mellitus in Patients with Hidradenitis Suppurativa—A Monocentric Study in Germany by Nessr Abu Rached, Thilo Gambichler, Lennart Ocker, Johannes W. Dietrich, Daniel R. Quast, Christina Sieger, Caroline Seifert, Christina Scheel, Falk G. Bechara
Published 2023-04-01
Article -
8
Measuring Quality of Life in Hidradenitis Suppurativa: Development and Validation of a Disease-specific Patient-reported Outcome Measure for Practice and Research by Marina Otten, Matthias Augustin, Christine Blome, Janine Topp, Marina Niklaus, Caroline Hilbring, Falk G. Bechara, Andreas Pinter, Christos C. Zouboulis, Florian Anzengruber, Natalia Kirsten
Published 2023-01-01
Article -
9
Switching from Adalimumab Originator to Biosimilar in Patients with Hidradenitis Suppurativa Results in Losses of Response—Data from the German HS Registry HSBest by Natalia Kirsten, Frenz Ohm, Kathrin Gehrdau, Gefion Girbig, Brigitte Stephan, Nesrine Ben-Anaya, Andreas Pinter, Falk G. Bechara, Dagmar Presser, Christos C. Zouboulis, Matthias Augustin
Published 2022-09-01
Article -
10
Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial by Alexa B. Kimball, Errol P. Prens, Thierry Passeron, Emanual Maverakis, Irina Turchin, Stefan Beeck, Leonidas Drogaris, Ziqian Geng, Tianyu Zhan, Izabella Messina, Falk G. Bechara
Published 2023-03-01
Article